The human kinome contains 518 proteins. They share a common mechanism of
protein phosphorylation known to play an important role in cellular
signaling pathways. Impaired kinase function is recognized to be
involved in severe diseases like cancer. The challenge of this PhD work
is the in silico identification of potentially interesting molecules
concerning the inhibitory process of a set of protein kinases, namely
PIM1, PIM2, CDC7, DRAK2 and CAMKIIδ. The faculty of this protein to
interact in differentiation, proliferation and tissue repair phenomena
makes their inhibitions crucial for treatments against tumor development
in which they are involved. Despites their interests, until now there is
no molecule acting on theses kinases has been proven by the Food and
Drug Administration. In this way, the authors will focus, in this book
on several in silico methods for rational drug design of new kinases
inhibitors.